Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1922194109
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10701 Vintage Preserve Pkwy
Houston, TX, 77070
Phone (713) 442-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,538
68 services
Medicare patients, 2024
12
Average age 70
Drug cost, 2024
$2.9M
7,908 prescriptions
Company payments, 2024
$67.9
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Shahid Muhammad prescribed most often to Medicare patients was Levothyroxine Sodium, with 717 prescriptions and refills. In total Shahid Muhammad wrote 7,908 Medicare prescriptions that cost $2.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 717 | 2,094 | 218 | $3,250 |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 462 | 622 | 102 | $765K |
| Novolog Flexpen Insulin Aspart | 456 | 748 | 125 | $133K |
| Ozempic Semaglutide | 414 | 534 | 86 | $497K |
| Metformin Hcl Generic | 360 | 1,045 | 118 | $5,943 |
| Alendronate Sodium Generic | 280 | 731 | 97 | $5,035 |
| Jardiance Empagliflozin | 237 | 409 | 53 | $233K |
| Glipizide Generic | 234 | 657 | 83 | $3,060 |
| Atorvastatin Calcium Generic | 219 | 653 | 66 | $7,060 |
| Rybelsus Semaglutide | 194 | 309 | 52 | $279K |
| Tresiba Flextouch U-100 Insulin Degludec | 179 | 271 | 53 | $122K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 148 | 397 | 66 | $16K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 146 | 279 | 47 | $91K |
| Trulicity Dulaglutide | 146 | 175 | 33 | $167K |
| Metformin Hcl Er Metformin Hcl | 143 | 424 | 53 | $3,245 |
Brand drugs: 3,123 claims; generic drugs: 4,418 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Shahid Muhammad $67.9 ($67.9 in general payments such as food, travel and fees) from 1 company. The largest payer was Biosense Webster, Inc. with $67.9.
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. JNJ | 1 | $67.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.